Adit Dharia: Exploring The Next Wave of Personalized Immuno-Oncology in GI Malignancies
Adit Dharia, Chief Medical Resident at HCA Florida Oak Hill Hospital, shared a post on LinkedIn:
“Thrilled to share that our review article, “Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications,” is now published in Antibodies (MDPI)!
In this comprehensive review, we dive into how immunotherapy has transformed the treatment landscape for GI cancers, including colorectal, gastric, esophageal, liver, biliary, and pancreatic malignancies. We summarize key trials and discuss their implications for current practice and ongoing challenges.
We also explore emerging strategies and future directions, including novel combinations that may shape the next wave of personalized immuno-oncology in GI malignancies.
I am grateful to my co-authors and mentors for their support on this meaningful project.”
Title: Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications
Authors: Supriya Peshin, Faizan Bashir, Naga Anvesh Kodali, Adit Dharia, Sajida Zaiter, Sakshi Singal, Nagaishwarya Moka
Read The Full Article at MDPI.
More Posts Featuring GI Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023